Quality of Life Analysis of Arimidex Treatment in Postmenopausal Patients With Breast Cancer
Phase of Trial: Phase IV
Latest Information Update: 05 Jun 2012
At a glance
- Drugs Anastrozole (Primary)
- Indications Early breast cancer
- Focus Therapeutic Use
- Acronyms RADAR II E
- Sponsors AstraZeneca
- 05 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Jul 2009 Planned end date changed from 1 May 2010 to 1 Jul 2010 as reported by ClinicalTrials.gov record.